Looks to me that the injectables have now been proved up to a potential moneymaker for POH.
Why bother fighting for something that won't provide a return?
Mid 2016, the other companies will launch their generic Daptomycin. Great incentive for Mylan to settle before that date.
Not as bad as the market seems to think
Looks to me that the injectables have now been proved up to a...
-
- There are more pages in this discussion • 286 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 54 | 94538418 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 75689350 | 20 |
View Market Depth
| Last trade - 12.31pm 04/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable